Study Stopped
Study manager's decision
Functional Evaluation of the Fetal Lung by Functional Magnetic Resonance Imaging - Blood Oxygenation Level Dependent (MRI-BOLD), in Congenital Diaphragmatic and Parietal Malformations
BOLD FETUS
Functional Magnetic Resonance Imaging - Blood Oxygenation Level Dependent (MRI-BOLD) of the Feta Lung in Congenital Diaphragmatic and Parietal Malformations
2 other identifiers
interventional
N/A
1 country
1
Brief Summary
The objective is to evaluate the quality of the response to the Blood Oxygen Level Dependent effect in fetuses with diaphragmatic hernias and abdominal wall malformations and to correlate with postnatal respiratory outcome. Pulmonary involvement is a constant in diaphragmatic hernias, it is classic in omphaloceles and especially hepatomphaloceles, and exceptional in laparoschisis. As this is an original exploratory study, no preliminary data are available. If a correlation is found, the Blood Oxygen Level Dependent effect of the fetal lung may be considered as an early functional marker of postnatal lung function. It can be used in addition to lung-to-head-ratio during prenatal counseling. The final goal is to be able to detect early in the fetus pulmonary insufficiency to help prenatal counseling and perinatal care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started May 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 2, 2019
CompletedFirst Posted
Study publicly available on registry
December 4, 2019
CompletedStudy Start
First participant enrolled
May 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2022
CompletedMarch 12, 2026
March 1, 2026
2 years
December 2, 2019
March 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Value of the Blood Oxygenation Level Dependent of the fetal lung
Regions of interest (ROI) were manually identified on MRI images, with the largest possible homogenous 2D area. For the lungs, the ROIs were delineated at the maximal chest circumference, delineating the right lung, the left lung. Changes in haemoglobin concentration will be evaluated by the variation in transverse R2\* signal induced by oxygenation in the delimited ROI. The BOLD response will be calculated for each case as the difference between normoxic and hyperoxic period (∆R2\*) normalized by normoxic value: ∆R2\* = \[R2\*(norm)-R2\*(hyper)\] / R2\*(norm).
30 months
Postnatal respiratory evolution
Duration of mechanical ventilation
30 months
Secondary Outcomes (3)
Postnatal survival
30 months
Duration of oxygen dependence
30 months
Length of hospitalization
30 months
Study Arms (1)
Congenital diaphragmatic and parietal malformations
EXPERIMENTALPatients with fetal magnetic resonance imaging as part of their usual medical care, for fetal / placental indications of diaphragmatic hernia, omphalocele or gastroschisis.
Interventions
First Functional magnetic resonance imaging - Blood Oxygenation Level Dependent sequence under ambient air. Oxygenation of 5 minutes at a rate of 12 l / min. Second Functional magnetic resonance imaging - Blood Oxygenation Level Dependent sequence.
Eligibility Criteria
You may qualify if:
- Major patient,
- patient with a simple pregnancy,
- patient between 28 and 33 weeks of amenorrhea,
- patient undergoing fetal MRI as part of their usual care, for fetal / placental indications : diaphragmatic hernia, omphalocele and laparoschisis,
- informed consent signed by the patient and the investigator,
- patient affiliated to a social security scheme (beneficiary or beneficiary).
You may not qualify if:
- Patient with one of the usual contraindications for MRI,
- claustrophobic patient,
- patient with an abdominal perimeter\> 125 cm,
- patient with multiple-birth pregnancy,
- patient with a pregnancy at the end of a long course of medical assisted procreation,
- patient with chronic respiratory disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital Necker-Enfants Malades
Paris, 75015, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Naziha KHEN-DUNLOP, MD, PhD
Assistance Publique - Hôpitaux de Paris
- STUDY DIRECTOR
Laurent SALOMON, MD
Assistance Publique - Hôpitaux de Paris
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 2, 2019
First Posted
December 4, 2019
Study Start
May 1, 2020
Primary Completion
May 1, 2022
Study Completion
May 1, 2022
Last Updated
March 12, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share